Heather Feldman
Medical · Fall River, MANPI 1306154513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 36.2% of the total. Reporting peaked in 2021 at $697 and has fallen 68.4% since, to $220 in 2025.
Across 82 payments — averaging $26.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$777
- Boehringer Ingelheim$199
- GSK$179
- Covis Pharma GmbH$128
- Incyte Corporation$122
- Takeda Pharmaceuticals U.S.A., Inc.$112
- plus $632 from 14 others
What the payments were for
- Food & beverage$2,13899%
- Education$111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $777 |
| Boehringer Ingelheim | 7 | $199 |
| GSK | 11 | $179 |
| Covis Pharma GmbH | 7 | $128 |
| Incyte Corporation | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Pharmacosmos Therapeutics Inc. | 1 | $104 |
| Inari Medical, Inc. | 1 | $101 |
| Sanofi | 3 | $91 |
| Mylan Specialty L.p. | 5 | $91 |
| Amgen | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Pfizer | 2 | $34 |
| Electromed, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$223
- JAKAFI$122
- CALQUENCE$116
- Monoferric$104
- FLOWTRIEVER CATHETER, S$101
- CT THROMBECTOMY SYSTEM KIT$101
How this compares
$2,149 in reported general payments places this provider in the 85th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $9,909 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $7,667 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,201 |
| Letrozole | 29 | $624 |
| Anastrozole | 21 | $402 |
| Tamoxifen Citrate | 13 | $369 |
| Oxycodone Hcl | 14 | $180 |
| Montelukast Sodium | 22 | $166 |
| Fluticasone Propionate | 11 | $123 |
| Omeprazole | 12 | $114 |
| Gabapentin | 12 | $107 |
| Prednisone | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $9,90915 claims |
| GSKAnoro Ellipta | $179 | $7,66719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 421 medical providers in Massachusetts.
Other medical in Fall River
- Jennifer LevesqueFall River$15K
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.